REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/10/2025
Voltar para busca
Dado oficial do USPTO
YOUR FAVORITE GENES IN YOUR FAVORITE CELL
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
YOUR FAVORITE GENES IN YOUR FAVORITE CELL
ST13
US500000087069198Classe
42
Pedido
87069198
Registro
6166553
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
67
Atualização mais recente
07/10/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42
Data de depósito
13/06/2016
Data de registro
06/10/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
06/10/2020
Última transação
07/10/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
2016-05-00
Primeiro uso no comércio
2016-05-00
Código do desenho
4
Tipo de titular
03
Localização do titular
MINNEAPOLIS, MN
Examinador
AGOSTO,GISELLE MARIE
Unidade examinadora
L20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
RESEARCH AND DIAGNOSTIC SYSTEMS, INC.
B-MoGen Biotechnologies, Inc.
Representantes
Courtney Thompson Fredrikson & Byron, P.A.
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Custom cell-line engineering services; Scientific research in the field of genetics and genetic engineeringgene-editing servicesDNA modeling servicesgene engineering servicesestablishing patient genotypes; Bio-technologypharmaceutical and scientific testing for scientific research purposesresearch and development services relating to genetics; biological research; pharmaceutical research services; drug discovery services; Scientific research and development services for lead identification and validation; Scientific research and development services for target identification and validation; Pharmaceutical researchidentification of patient-relevant drug targetsoptimization of drug candidates for clinical development; Laboratory diagnostic services for research purposesdiagnosis of genetic mutations for clinical or research purposes and the design of molecular reference standards for assay developmentclinical diagnostic quality control and proficiency schemes for the medical diagnostic services industry; medicinal research serviceshit discovery and hit to lead services; research and development services in the nature of creating libraries and collections of cells and cell lineschemicals and compounds; research and development services in the nature of creating libraries and collections of normal and mutated genes; Scientific research and development services relating to targeting therapies to individuals; Scientific research and development services relating to combining therapies for individuals; research and development relating to reagents; Scientific research in the field of disease modeling; Medical and scientific researchdesigning and conducting clinical trials for others; research and development in re-positioning existing drugs from other therapeutic indications
Publicações
Histórico de despachos e eventos da marca no USPTO.
67 publicações encontradas
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
29/08/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/05/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/05/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
08/05/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/05/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/05/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/05/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
06/10/2020
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
01/09/2020
MREI
NOTICE OF REINSTATEMENT E-MAILED
28/08/2020
PC.D
PETITION TO DIRECTOR DISMISSED
27/08/2020
RGIA
REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED
27/08/2020
APET
ASSIGNED TO PETITION STAFF
27/08/2020
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
24/08/2020
ABN6
ABANDONMENT - NO USE STATEMENT FILED
24/08/2020
IUCN
NOTICE OF ALLOWANCE CANCELLED
02/07/2020
TPDR
TEAS PETITION TO DIRECTOR RECEIVED
02/07/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
31/03/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
31/03/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
31/03/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
31/03/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
31/03/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
24/01/2020
EX5G
SOU EXTENSION 5 GRANTED
23/01/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
23/01/2020
EXT5
SOU EXTENSION 5 FILED
20/01/2020
EEXT
SOU TEAS EXTENSION RECEIVED
20/01/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
20/01/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
20/07/2019
EX4G
SOU EXTENSION 4 GRANTED
18/07/2019
EXT4
SOU EXTENSION 4 FILED
18/07/2019
EEXT
SOU TEAS EXTENSION RECEIVED
18/07/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
22/01/2019
EX3G
SOU EXTENSION 3 GRANTED
18/01/2019
EXT3
SOU EXTENSION 3 FILED
18/01/2019
EEXT
SOU TEAS EXTENSION RECEIVED
18/01/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/09/2018
EX2G
SOU EXTENSION 2 GRANTED
11/09/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/09/2018
NREV
NOTICE OF REVIVAL - E-MAILED
19/07/2018
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
19/07/2018
PETG
PETITION TO REVIVE-GRANTED
19/07/2018
PROA
TEAS PETITION TO REVIVE RECEIVED
19/07/2018
EXT2
SOU EXTENSION 2 FILED
18/07/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
20/01/2018
EX1G
SOU EXTENSION 1 GRANTED
18/01/2018
EXT1
SOU EXTENSION 1 FILED
18/01/2018
EEXT
SOU TEAS EXTENSION RECEIVED
18/01/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
18/07/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/05/2017
PUBO
PUBLISHED FOR OPPOSITION
23/05/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/05/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/04/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
18/04/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
18/04/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
18/04/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
18/04/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/03/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/03/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/03/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
27/09/2016
GNRT
NON-FINAL ACTION E-MAILED
27/09/2016
CNRT
NON-FINAL ACTION WRITTEN
27/09/2016
DOCK
ASSIGNED TO EXAMINER
22/09/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/06/2016
NWAP
NEW APPLICATION ENTERED
16/06/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace YOUR FAVORITE GENES IN YOUR FAVORITE CELL ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.